TOBAM – Alnylam Pharmaceuticals, Inc. Transaction History
TOBAM portfolio value:
$20.18M
portfolio value
TOBAM quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -44.00% | -79.23K shares | -6.07M | $200.16 | 100.86K |
| Q2 2022 | share | Increase | +15.76% | 24.51K shares | 863K | $145.85 | 180.10K |
| Q1 2022 | share | Increase | +90.08% | 73.73K shares | 11.52M | $163.29 | 155.58K |
| Q4 2021 | share | Increase | +790.29% | 72.65K shares | 12.14M | $171.03 | 81.85K |
| Q3 2021 | share | Increase | +6.20% | 537 shares | 268K | $188.81 | 9.19K |
| Q2 2021 | share | Decrease | -77.47% | -29.76K shares | -3.95M | $169.52 | 8.65K |
| Q1 2021 | share | Decrease | -49.63% | -37.86K shares | -4.49M | $141.19 | 38.42K |
| Q4 2020 | share | Increase | +7.20% | 5.12K shares | -446K | $129.97 | 76.28K |
| Q3 2020 | share | Increase | +43.04% | 21.41K shares | 2.99M | $145.6 | 71.16K |
| Q2 2020 | share | Increase | 0.00% | 49.74K shares | 7.36M | $148.11 | 49.74K |
| Q3 2019 | share | Decrease | -100.00% | -844 shares | -61K | $80.42 | 0 |
| Q2 2019 | share | Decrease | -99.27% | -115.35K shares | -10.79M | $72.56 | 844 |
| Q1 2019 | share | Decrease | -57.53% | -157.40K shares | -9.09M | $93.45 | 116.20K |
| Q4 2018 | share | Increase | +11.78% | 28.82K shares | -1.47M | $72.91 | 273.60K |
| Q3 2018 | share | Decrease | -14.92% | -42.93K shares | -6.91M | $87.52 | 244.78K |
| Q2 2018 | share | Increase | +37.37% | 78.26K shares | 3.39M | $98.49 | 287.71K |
| Q1 2018 | share | Increase | +87.76% | 97.89K shares | 10.77M | $119.1 | 209.44K |
| Q4 2017 | share | Increase | 0.00% | 111.55K shares | 14.17M | $127.05 | 111.55K |